DKK1 and hepatocellular carcinoma: DKK1 promotes inflammation, cell migration, and invasion in HCC via TGF-1-mediated remodeling of the TME, while it exerts oncogenic effects in HepG2/C3C cell lines and thus is a promising target for HCC immunotherapy [169].